Vertigo Treatments Market, By Type (Central Vertigo and Peripheral Vertigo), By Treatment (Medication and Surgery/Therapy), By Route of Administration (Oral, Topical, Parenteral, and Others), By End User (Hospitals, Clinics, and Others), By Geography (Nor

Vertigo Treatments Market, By Type (Central Vertigo and Peripheral Vertigo), By Treatment (Medication and Surgery/Therapy), By Route of Administration (Oral, Topical, Parenteral, and Others), By End User (Hospitals, Clinics, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Vertigo refers to a condition where a person feels as if they or everything around them is moving or spinning, even though they are stationary. It is typically caused due to imbalance in the inner ear. Aging population has contributed greatly to the rising prevalence of vertigo across major markets. According to the National Library of Medicine estimates in June 2023, over 12% of adults aged 60 years and above experience vertigo at least once in their lifetime. Various treatment options are available for vertigo including medications, vestibular rehabilitation therapy, balance retraining programs, surgical treatments, etc. Advancements in diagnosis and introduction of novel therapeutics are supporting the market expansion.

Market Dynamics:

Rising geriatric populace, growing cases of neurological disorders causing vertigo, and new product approvals and launches are some of the key factors driving the global vertigo treatments market. However, risks associated with surgical treatments, social stigma around vertigo and high costs of branded therapies are certain challenges restraining the market growth. On the opportunities side, untreated vertigo imposes a huge economic burden globally. Growing medical tourism in developing nations and technological developments in vertigo management devices present valuable prospects for market players. Collaborations between medical device innovators and healthcare providers can help address unmet needs more effectively.

Key Features of the Study:

• This report provides in-depth analysis of the global vertigo treatments market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global vertigo treatments market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medtronic Abbott Laboratories, Siemens Healthineers, Johnson & Johnson, Oticon, Cochlear Limited, Auris Medical Holding AG, Otonomy, Inc., Sensorion SA, Sound Pharmaceuticals Inc., GSK (GlaxoSmithKline), Merck & Co., Pfizer Inc., Novartis AG, and Bayer AG
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global vertigo treatments market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vertigo treatments market

Market Segmentation

• By Type Insights (Revenue, USD Bn, 2019 - 2031)
• Central Vertigo
• Peripheral Vertigo
• By Treatment Insights (Revenue, USD Bn, 2019 - 2031)
• Medication
• Anticholinergics
• Antihistamines
• Benzodiazepines
• Others
• Surgery/Therapy
• By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
• Oral
• Topical
• Parenteral
• Others
• By End User Insights (Revenue, USD Bn, 2019 - 2031)
• Hospitals
• Clinics
• Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• Medtronic
• Abbott Laboratories
• Siemens Healthineers
• Johnson & Johnson
• Oticon
• Cochlear Limited
• Auris Medical Holding AG
• Otonomy, Inc.
• Sensorion SA
• Sound Pharmaceuticals, Inc.
• GSK (GlaxoSmithKline)
• Merck & Co.
• Pfizer Inc.
• Novartis AG
• Bayer AG